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Tuberculosis remains one of the major problems in publichealth, with 9 million new cases and the deaths of around 1.5
million people each year (1). During the last 10 years the tubercu-
losis incidence and mortality rate in Kazakhstan decreased to
52.4% and 72.8%, respectively, but high tuberculosis incidences
andmortality rates still exist. Thus, the tuberculosis incidence and
mortality rate were 73.4 and 5.6 per 100,000 people in 2013, re-
spectively, whereas in 2012 the same indicators were 81.7 and 7.4
per 100,000 (2).
Despite progress in decreasing the global incidence of drug-
susceptible tuberculosis, the existence of multidrug-resistant
(MDR) and extensively drug-resistant (XDR) tuberculosis has led
to decreasing efficiency of chemotherapy and prolonged treat-
ment (1). Kazakhstan is 1 of 18 countries in the WHO European
Region with a high rate of MDR tuberculosis (2).
It is extremely important to examine sensitive and resistant
strains with different mutations in genes encoding drug metabo-
lism amongMycobacterium tuberculosis strains from the different
geographic regions of Kazakhstan. Some previous studies have
been performed in Kazakhstan by using Sanger sequencing and
genotyping methods (3, 4). Here, we report the draft genome se-
quences of two clinical isolates of M. tuberculosis, isolated from
sputum of Kazakh patients, performed by using a next-generation
sequencing platform.
Material collection, sputumandDNAextraction, and determi-
nation of drug sensitivity of twoM. tuberculosis isolates MTB-476
and MTB-489 were performed at the reference laboratory “Na-
tional Center of Tuberculosis Problems,” Kazakhstan. DNA shot-
gun libraries were prepared by using a GS FLX Titanium rapid
library preparation kit. Whole-genome sequencing of the two
M. tuberculosis isolates was performed by using a Roche 454 GS
FLX next-generation sequencing (NGS) platform at the Centre
for Life Sciences, Nazarbayev University, Kazakhstan.
The run yielded 96 Mb and 104.2 Mb, with 184,296 and
176,838 passed filters, average lengths of 520.2 and 589.3 bp, and
21.8 and 23.7 coverage for the MTB-476 and MTB-489, re-
spectively. The sequencing readswere then de novo assembled into
contigs using Newbler v.2.8. The draft genome annotations were
performed using the NCBI Prokaryotic Genome Annotation
Pipeline (http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline
.html) and xBASE, which uses Glimmer (5) for gene prediction,
and tRNAsacn-SE (6) andRNAmmer (7) forRNAprediction. The
contigs were aligned and ordered against M. tuberculosis H37Rv
using Mauve v.2.3.1 (8). Synteny evaluation and visualization
were carried out using C-Sibelia (9) and Circos (10). The genome
of M. tuberculosis MTB-476 consists of 257 contigs with a GC
content of 65.2% and 4,204 predicted coding sequences, 46
tRNAs, and 3 rRNAs. The genome ofM. tuberculosisMTB-489 has
187 contigs, withGC content of 65.3% and 4,183 predicted cod-
ing sequences, 45 tRNAs, and 3rRNAs. This draft genome data
may provide a basis for creation of the reference database, the
subsequent study, and comparison with the different drug-
resistant M. tuberculosis isolates circulating in Kazakhstan.
Nucleotide sequence accession numbers. The draft genome
sequences of the M. tuberculosis isolates MTB-476 and MTB-489
have been deposited at DDBJ/EMBL/GenBank under the acces-
sion numbers AZBA00000000 and AZAZ00000000. The versions
described in this paper are the first versions, accession numbers
AZBA01000000 and AZAZ01000000 (BioProject PRJNA229943
and PRJNA229941).
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